Search Results 1421-1430 of 20159 for Hepatitis C

1. Mayo Clinic Transplant Center - Doctors

   Displaying 11-14 out of 14 doctors available. Last Name Initial: C. Alex Cortez, M.D.. Transplant Surgeon.

2. Dolutegravir and lamivudine (oral route) - Mayo Clinic

   Hepatitis B or C infection—Use with caution. May make this condition worse. Kidney disease or; Liver disease, severe—Use is not recommended in patients with ...

3. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

   Active tuberculosis or recent (< 2 week) clinically significant infection, or evidence of active hepatitis B or hepatitis C. Known history of positive test ...

4. Cholecystectomy (gallbladder removal) - Doctors & Departments - Mayo Clinic

   Displaying 1-1 out of 1 doctors available. Last Name Initial: C. Alex Cortez, M.D.. Transplant Surgeon.

5. Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma - Mayo Clinic

   of study intervention. - Active infection including TB, HIV, hepatitis A, chronic or active hepatitis B, chronic or active hepatitis C, active COVID-19 ...

6. A Study To Evaluate The Onset Of Effect And Time Course Of Change In Lung Function With Benralizumab In Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

   Positive hepatitis B surface antigen, or hepatitis C virus antibody serology, or a positive medical history for hepatitis B or C. Patients with a history of ...

7. Laboratory Assay Optimization 2.0 - Clinical Trials

   HIV positive donors and/or Hepatitis C Virus (HCV) positive and/or recovered SARS-CoV-2 positive adult (≥18 years of age) donors will be recruited for ...

8. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Active hepatitis B, active hepatitis C, or positive for human immunodeficiency virus (HIV). Uncontrolled, clinically significant pulmonary disease (for ...

9. Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris - Mayo Clinic

   Known history of hepatitis B, hepatitis C, or tuberculosis; Personal or family history of inflammatory bowel disease. Participating Mayo Clinic locations.

10. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    The atezolizumab plus interferon alfa-2b arm (Arm B), plus pegylated interferon alfa-2a (PEG−interferon alfa-2a, Arm C) ... Participants with active hepatitis C ...